Unexpected antibody distribution among tumor patients: analysis of 111 483 cases

Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 9

Abstract

Objective To analyze the distribution of unexpected antibodies in tumor patients retrospectively and explore the clinical significance. Methods Unexpected antibody screening was performed on inpatients with blood preparation and blood transfusion in our hospital from January 2004 to December 2022, with 1 176 cases tested positive, and the types of unexpected antibodies and distribution characteristics were statistically analyzed. Results Unexpected antibodies were screened in 1 176 cases, with the positive rate at 1.05% (1 176/111 483). The unexpected antibodies were mainly anti-E 16.33%(192/1 176), anti-M 7.99% (94/1 176), anti-Mur 5.70% (67/1 176) and anti-Lea 4.76% (56/1 176). Among the 1 176 cases, gastrointestinal tumors accounted for 27.99% (329/1 176), gynecological tumors accounted for 24.84% (292/1 176), respiratory tumors accounted for 16.67% (196/1 176) . Conclusion The influencing factors of unexpected antibodies in tumor patients were disease type, blood transfusion history and blood type. Therefore, it is necessary for clinical departments to carry out unexpected antibody screening and perform Rh blood type matched transfusion for tumor patients to avoid alloantibody production.

Authors and Affiliations

Haiyu ZHANG, Ke ZHANG, Hongzhou WU, Lijun ZHONG, Zuo WANG, Guihua ZHANG, Yannan FENG, Li CHEN, Lian DAI, Shanshan WAN

Keywords

Related Articles

Bioactive ingredients in activated platelet-rich plasma derived from cord blood and adult blood via Luminex technology: a comparative study

Objective To compare the bioactive ingredients in activated platelet-rich plasma (PRP) from cord blood and adult blood, explore its reasonable indicators reflecting the inflammatory regulation ability, in order to guide...

Blood security and management of transfusion-dependent thalassaemia (TDT) patients in Nanning: analysis of " collection-based-supply" blood management mode

Objective To retrospectively analyze the blood use of transfusion-dependent thalassemia (TDT) patients in 9 designated transfusion medical institutions from 2018 to 2023 in Nanning, and to evaluate the effect of " three...

Stability of temperature field in blood refrigerated warehouse using micro-hole air inlet

Objective To study the effect of air inlet modes on the temperature variation, fluctuation, uniformity and coefficient of variation(CV), so as to evaluate the stability and uniformity of the temperature field in refriger...

Study on separation and purification process of C1 esterase inhibitor

Objective To study the technology of separating and purifying C1 esterase inhibitor (C1-INH) by using the waste washing liquid as raw materia during the preparation of human prothrombin complex (PCC) l. Methods C1-INH wa...

Optimization of large-scale production process for human prothrombin complex concentrates

Objective To determine the optimal process conditions for efficiently extracting human prothrombin complex concentrates from human plasma. Methods Using human plasma as the materials and the yield of prothrombin complex...

Download PDF file
  • EP ID EP738638
  • DOI 10.13303/j.cjbt.issn.1004-549x.2023.09.011
  • Views 43
  • Downloads 0

How To Cite

Haiyu ZHANG, Ke ZHANG, Hongzhou WU, Lijun ZHONG, Zuo WANG, Guihua ZHANG, Yannan FENG, Li CHEN, Lian DAI, Shanshan WAN (2023). Unexpected antibody distribution among tumor patients: analysis of 111 483 cases. Chinese Journal of Blood Transfusion, 36(9), -. https://europub.co.uk/articles/-A-738638